MGB Biopharma Limited
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD (NCT03824795) | MGB Biopharma Limited | 2019-02-07 |
| Safety, Blood Levels and Effects of MGB-BP-3 (NCT02518607) | MGB Biopharma Limited | 2015-07-01 |
Track MGB Biopharma Limited automatically
Every clearance here is in the API, with alerts when new ones post.